Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis
Open Access
- 1 November 2004
- Vol. 59 (11), 948-951
- https://doi.org/10.1136/thx.2003.017210
Abstract
Introduction:Burkholderia cepacia infection has been associated with a poor prognosis for patients with cystic fibrosis (CF). It is now recognised that organisms classified as B cepacia comprise a number of distinct genomic species each known as a genomovar of the B cepacia complex (BCC). The outcome of infection for CF patients with individual genomovars is unknown. The clinical outcome of infection with the two most commonly isolated genomovars (B cenocepacia and B multivorans) was studied at a specialist CF centre between 1982 and 2003. Methods: The numbers of patients who progressed from initial to chronic infection were assessed. Control groups were created by matching patients with chronic BCC infection by percentage forced expiratory volume in 1 second with patients with Pseudomonas aeruginosa infection. Outcome measures were survival time, deaths from “cepacia syndrome”, rate of decline in spirometry and body mass index (BMI), and treatment requirements. Results: Forty nine patients had an initial infection with either B multivorans (n = 16) or B cenocepacia (n = 33); 8/16 and 31/33, respectively, developed chronic infection (pcepacia syndrome” occurred in both BCC groups. Patients with B cenocepacia infection had a shorter survival than patients with P aeruginosa infection (p = 0.01). There was no difference in survival between CF patients infected with B multivorans and P aeruginosa. There were no observed differences in changes in spirometry and BMI or treatment requirements between the BCC groups and respective controls. Conclusion: In CF, the genomovar status of BCC may influence both the likelihood of progression from initial to chronic infection and the overall survival of the patients.Keywords
This publication has 13 references indexed in Scilit:
- Lung Transplantation for Cystic Fibrosis Patients with Burkholderia cepacia ComplexAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosisThe Lancet, 2001
- Infection withBurkholderia cepaciaComplex Genomovars in Patients with Cystic Fibrosis: Virulent Transmissible Strains of Genomovar III Can ReplaceBurkholderia multivoransClinical Infectious Diseases, 2001
- Disproportionate Distribution of Burkholderia cepacia Complex Species and Transmissibility Markers in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Infection with Burkholderia cepacia in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Burkholderia cepacia in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Cross infection between cystic fibrosis patients colonised with Burkholderia cepaciaThorax, 1998
- Occurrence of Multiple Genomovars of Burkholderia cepacia in Cystic Fibrosis Patients and Proposal of Burkholderia multivorans sp. nov.International Journal of Systematic and Evolutionary Microbiology, 1997
- Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic.Thorax, 1996
- Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosisThe Lancet, 1993